Wat is de prijs voor DermTech, Inc. (DMTK)

Het prijs van DermTech, Inc. (DMTK) is $0.069

Wat is de marktkapitalisatie voor DermTech, Inc. (DMTK)

Marktkapitalisatie voorDermTech, Inc. (DMTK) is $2.06M

DermTech, Inc. (DMTK) Uitstaande Aandelen

DermTech, Inc., a molecular diagnostics firm headquartered in La Jolla, California, specializes in creating and bringing to market advanced, non-invasive genomic tests. Operating within the United States, their innovative solutions facilitate the diagnosis of various dermatological issues, including skin cancer, inflammatory conditions, and age-related skin concerns. A cornerstone of their offerings is the DermTech Melanoma Test (DMT), a sophisticated gene expression analysis. This assay plays a crucial role in enhancing the early identification of genomic abnormalities, effectively aiding in the exclusion of melanoma and often removing the need for invasive surgical biopsies of suspicious pigmented lesions. The company further provides specialized adhesive kits for convenient skin sample collection. Additionally, they offer gene expression assays designed to analyze key inflammatory pathways such, as Th1, Th2, IFN-gamma, and Th17. Looking ahead, DermTech is actively developing a pipeline of new products, which includes DNA risk assessment tools for UV damage, diagnostic tests for non-melanoma skin cancers, and rule-out tests for cutaneous T-cell lymphoma. They also extend their services by delivering health-related information and support through digital and telecommunication platforms. DermTech's diagnostic products and services are primarily targeted towards medical professionals in the fields of pathology and oncology.

Jaar	Uitstaande aandelen	Wijzigen
2026 (TTM)	34.71M	6.33%
2023	32.64M	8.66%
2022	30.04M	4.00%
2021	28.89M	70.12%
2020	16.98M	142.38%
2019	7.01M	196.70%
2018	2.36M	29.52%
2017	1.82M	-61.36%
2013	4.72M	37.11%
2012	3.44M	0.00%

Jaar

Uitstaande aandelen

Wijzigen

2026 (TTM)

34.71M

6.33%

2023

32.64M

8.66%

2022

30.04M

4.00%

2021

28.89M

70.12%

2020

16.98M

142.38%

2019

7.01M

196.70%

2018

2.36M

29.52%

2017

1.82M

-61.36%

2013

4.72M

37.11%

2012

3.44M

0.00%

Bedrijf	Uitstaande aandelen	Verschil	Land
Thermo Fisher Scientific Inc. TMO.US	371.00M	968.98%	US
Danaher Corporation DHR.US	705.30M	1,932.21%	US
WuXi AppTec Co., Ltd. 603259.SS	-	-	CN
Natera, Inc. NTRA.US	143.28M	312.84%	US
IDEXX Laboratories, Inc. IDXX.US	80.10M	130.78%	US

Bedrijf

Uitstaande aandelen

Verschil

Land